Laetrile sparked hope and controversy in cancer cases
Anonymous La Crosse interviewees recount Laetrile use despite FDA bans. Some claim extended life and relief, while Mayo Clinic doctors caution biopsy necessity and warn of cyanide risks. People describe Mexico access, underground networks, costs, and mixed outcomes across several U.S. families.
MENTIONED IN THIS ARTICLE
Mexico
Food and Drug Administration
FDA
la Crosse
Laetrile Controversy Highlighted By Mayo Clinic Expert
Mayo Clinic center in Rochester discusses Laetrile as an unproven cancer treatment. Carr notes historical predecessors and public fear of cancer. FDA official Evans cites extensive testing showing no safety or efficacy and warns of cyanide risk. Critics argue abuse, cost, and lack of medical regulation, while proponents claim a cure or defense against cancer.
MENTIONED IN THIS ARTICLE
Mayo Clinic
Rochester
Minn
Mexico
FDA
William J. Evans
Texas
Carr
The
Food and Drug Administration
Evans
Sloan-Kettering Institute
Arthur D. Little Center
National Cancer Institute
Catholic Medical Center
American Medical Association
Also Mentioned on This Page
Laetrile
Minnesota
Iowa
Nelson
Nda Pati
Laetrile No Cure
SUN
Kmart
Eiderion
Texan
S. S Kresge Company
Our
Permanent Press
Eastman Reg
Parkas
Elanese
Prarmner
Fiber Industries Re
Ackets
Losey Blvd
Hwy
S. S. Kresge CO
Eiderlon